Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014 (2014), Article ID 254678, 13 pages
http://dx.doi.org/10.1155/2014/254678
Research Article

Investigation of the Novel Lead of Melanocortin 1 Receptor for Pigmentary Disorders

1Department of Biomedical Informatics, Asia University, Taichung 41354, Taiwan
2Department of Medicine, China Medical University, Taichung 40402, Taiwan
3Department of Biotechnology, Asia University, Taichung 41354, Taiwan
4China Medical University Beigang Hospital, Yunlin 65152, Taiwan
5Computational and Systems Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA

Received 18 November 2013; Revised 15 December 2013; Accepted 15 December 2013; Published 17 February 2014

Academic Editor: Fuu-Jen Tsai

Copyright © 2014 Hsin-Chieh Tang and Calvin Yu-Chian Chen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. E. Johnson, G. Mandell, and F. Daniels Jr., “Melanin and cellular reactions to ultraviolet radiation,” Nature, vol. 235, no. 57, pp. 147–149, 1972. View at Google Scholar · View at Scopus
  2. R. Cui, H. R. Widlund, E. Feige et al., “Central role of p53 in the suntan response and pathologic hyperpigmentation,” Cell, vol. 128, no. 5, pp. 853–864, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Y. Lin and D. E. Fisher, “Melanocyte biology and skin pigmentation,” Nature, vol. 445, no. 7130, pp. 843–850, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. D. E. Fisher and W. D. James, “Indoor tanning—science, behavior, and policy,” The New England Journal of Medicine, vol. 363, no. 10, pp. 901–903, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. A. V. Schally, A. Arimura, and A. J. Kastin, “Hypothalamic regulatory hormones,” Science, vol. 179, no. 4071, pp. 341–350, 1973. View at Google Scholar · View at Scopus
  6. L. Proulx-Ferland, F. Labrie, and D. Dumont, “Corticotropin-releasing factor stimulates secretion of melanocyte-stimulating hormone from the rat pituitary,” Science, vol. 217, no. 4554, pp. 62–63, 1982. View at Google Scholar · View at Scopus
  7. T. A. Lugcr, T. Scholzen, and S. Grabbe, “The role of a-melanocyte-stimulating hormone in cutaneous biology,” Journal of Investigative Dermatology Symposium Proceedings, vol. 2, no. 1, pp. 87–93, 1997. View at Google Scholar · View at Scopus
  8. A. B. Lerner and J. S. McGuire, “Melanocyte-stimulating hormone and adrenocorticotrophic hormone. Their relation to pigmentation,” The The New England Journal of Medicine, vol. 270, pp. 539–546, 1964. View at Google Scholar · View at Scopus
  9. J. I. Harris and A. B. Lerner, “Amino-acid sequence of the α-melanocyte-stimulating hormone,” Nature, vol. 179, no. 4574, pp. 1346–1347, 1957. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Singh, A. Wilczynski, J. R. Holder et al., “Incorporation of a bioactive reverse-turn heterocycle into a peptide template using solid-phase synthesis to probe melanocortin receptor selectivity and ligand conformations by 2D1H NMR,” Journal of Medicinal Chemistry, vol. 54, no. 5, pp. 1379–1390, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. N. M. Barkey, N. K. Tafreshi, J. S. Josan et al., “Development of melanoma-targeted polymer micelles by conjugation of a melanocortin 1 receptor (MC1R) specific ligand,” Journal of Medicinal Chemistry, vol. 54, no. 23, pp. 8078–8084, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. C. K. Jayawickreme, J. M. Quillan, G. F. Graminski, and M. R. Lerner, “Discovery and structure-function analysis of α-melanocyte-stimulating hormone antagonists,” Journal of Biological Chemistry, vol. 269, no. 47, pp. 29846–29854, 1994. View at Google Scholar · View at Scopus
  13. S. Lim, S. Li, C. Lee, C. Yoon, J. Baik, and W. Lee, “Minimization of MC1R selectivity by modification of the core structure of α-MSH-ND,” Chemistry and Biology, vol. 8, no. 9, pp. 857–870, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Brabez, R. M. Lynch, L. Xu et al., “Design, synthesis, and biological studies of efficient multivalent melanotropin ligands: tools toward melanoma diagnosis and treatment,” Journal of Medicinal Chemistry, vol. 54, no. 20, pp. 7375–7384, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. H. R. Bourne and E. C. Meng, “Rhodopsin sees the light,” Science, vol. 289, no. 5480, pp. 733–734, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Palczewski, T. Kumasaka, T. Hori et al., “Crystal structure of rhodopsin: a G protein-coupled receptor,” Science, vol. 289, no. 5480, pp. 739–745, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Vinós, K. Jalink, R. W. Hardy, S. G. Britt, and C. S. Zuker, “A G protein-coupled receptor phosphatase required for rhodopsin function,” Science, vol. 277, no. 5326, pp. 687–690, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. A. J. Venkatakrishnan, X. Deupi, G. Lebon et al., “Molecular signatures of G-protein-coupled receptors,” Nature, vol. 494, no. 7436, pp. 185–194, 2013. View at Google Scholar
  19. K. G. Mountjoy, L. S. Robbins, M. T. Mortrud, and R. D. Cone, “The cloning of a family of genes that encode the melanocortin receptors,” Science, vol. 257, no. 5074, pp. 1248–1251, 1992. View at Google Scholar · View at Scopus
  20. P. M. C. Lembo, E. Grazzini, J. Cao et al., “The receptor for the orexigenic peptide melanin-concentrating hormone is a G-protein-coupled receptor,” Nature Cell Biology, vol. 1, no. 5, pp. 267–271, 1999. View at Google Scholar · View at Scopus
  21. B. Borowsky, M. M. Durkin, K. Ogozalek et al., “Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist,” Nature Medicine, vol. 8, no. 8, pp. 825–830, 2002. View at Google Scholar
  22. C. Lalueza-Fox, H. Römpler, D. Caramelli et al., “A melanocortin 1 receptor allele suggests varying pigmentation among Neanderthals,” Science, vol. 318, no. 5855, pp. 1453–1455, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. N. I. Mundy, N. S. Badcock, T. Hart, K. Scribner, K. Janssen, and N. J. Nadeau, “Conserved genetic basis of a quantitative plumage trait involved in mate choice,” Science, vol. 303, no. 5665, pp. 1870–1873, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. H. E. Hoekstra, R. J. Hirschmann, R. A. Bundey, P. A. Insel, and J. P. Crossland, “A single amino acid mutation contributes to adaptive beach mouse color pattern,” Science, vol. 313, no. 5783, pp. 101–104, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Saito, H.-P. Nothacker, Z. Wang, S. H. S. Lin, F. Leslie, and O. Civelli, “Molecular characterization of the melanin-concentrating-hormone receptor,” Nature, vol. 400, no. 6741, pp. 265–269, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Sotomayor and K. Schulten, “Single-molecule experiments in vitro and in silico,” Science, vol. 316, no. 5828, pp. 1144–1148, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Levitt and A. Warshel, “Computer simulation of protein folding,” Nature, vol. 253, no. 5494, pp. 694–698, 1975. View at Google Scholar · View at Scopus
  28. B. Palsson, “The challenges of in silico biology,” Nature Biotechnology, vol. 18, no. 11, pp. 1147–1150, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. C. von Mering, R. Krause, B. Snel et al., “Comparative assessment of large-scale data sets of protein-protein interactions,” Nature, vol. 417, no. 6887, pp. 399–403, 2002. View at Google Scholar · View at Scopus
  30. B. Palsson, “In silico biology through ‘omics’,” Nature Biotechnology, vol. 20, no. 7, pp. 649–650, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Kitano, “Computational systems biology,” Nature, vol. 420, no. 6912, pp. 206–210, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. B. di Ventura, C. Lemerle, K. Michalodimitrakis, and L. Serrano, “From in vivo to in silico biology and back,” Nature, vol. 443, no. 7111, pp. 527–533, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. H. van de Waterbeemd and E. Gifford, “ADMET in silico modelling: towards prediction paradise?” Nature Reviews Drug Discovery, vol. 2, no. 3, pp. 192–204, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Puzyn, B. Rasulev, A. Gajewicz et al., “Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles,” Nature Nanotechnology, vol. 6, no. 3, pp. 175–178, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Liao, J. Wang, J. Guo et al., “In silico genetics: identification of a functional elements regulating HZ-Eα gene expression,” Science, vol. 306, no. 5696, pp. 690–695, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Pellecchia, “Fragment-based drug discovery takes a virtual turn,” Nature Chemical Biology, vol. 5, no. 5, pp. 274–275, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Bajorath, “Integration of virtual and high-throughput screening,” Nature Reviews Drug Discovery, vol. 1, no. 11, pp. 882–894, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. B. K. Shoichet, “Virtual screening of chemical libraries,” Nature, vol. 432, no. 7019, pp. 862–865, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Naylor, A. Arredouani, S. R. Vasudevan et al., “Identification of a chemical probe for NAADP by virtual screening,” Nature Chemical Biology, vol. 5, no. 4, pp. 220–226, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Duan and P. A. Kollman, “Pathways to a protein folding intermediate observed in a 1-microsecond simulation in aqueous solution,” Science, vol. 282, no. 5389, pp. 740–744, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Karplus and G. A. Petsko, “Molecular dynamics simulations in biology,” Nature, vol. 347, no. 6294, pp. 631–639, 1990. View at Publisher · View at Google Scholar · View at Scopus
  42. P. A. Bash, U. C. Singh, R. Langridge, and P. A. Kollman, “Free energy calculations by computer simulation,” Science, vol. 236, no. 4801, pp. 564–568, 1987. View at Google Scholar · View at Scopus
  43. J. P. Huelsenbeck, F. Ronquist, R. Nielsen, and J. P. Bollback, “Bayesian inference of phylogeny and its impact on evolutionary biology,” Science, vol. 294, no. 5550, pp. 2310–2314, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Karplus and J. A. McCammon, “Molecular dynamics simulations of biomolecules,” Nature Structural Biology, vol. 9, no. 9, pp. 646–652, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. J. A. D'Orazio, T. Nobuhisa, R. Cui et al., “Topical drug rescue strategy and skin protection based on the role of Mc1r in UV-induced tanning,” Nature, vol. 443, no. 7109, pp. 340–344, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Harms, S. Lautenschlager, C. E. Minder, and E. I. Minder, “An α-melanocyte-stimulating hormone analogue in erythropoietic protoporphyria,” The New England Journal of Medicine, vol. 360, no. 3, pp. 306–307, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Y. Chen, “Weighted equation and rules—a novel concept for evaluating protein-ligand interaction,” Journal of Biomolecular Structure and Dynamics, vol. 27, no. 3, pp. 271–282, 2009. View at Google Scholar · View at Scopus
  48. K. W. Chang, T. Y. Tsai, K. C. Chen et al., “iSMART: an integrated cloud computing web server for traditional Chinese medicine for online virtual screening, de novo evolution and drug design,” Journal of Biomolecular Structure and Dynamics, vol. 29, no. 1, pp. 243–250, 2011. View at Google Scholar · View at Scopus
  49. T. Y. Tsai, K. W. Chang, and C. Y. Chen, “IScreen: world's first cloud-computing web server for virtual screening and de novo drug design based on TCM database@Taiwan,” Journal of Computer-Aided Molecular Design, vol. 25, no. 6, pp. 525–531, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Y. Chen, “A novel integrated framework and improved methodology of computer-aided drug design,” Current Topics in Medicinal Chemistry, vol. 13, no. 9, pp. 965–988, 2013. View at Google Scholar
  51. W. I. Tou, S. S. Chang, C. C. Lee, and C. Y. Chen, “Drug design for neuropathic pain regulation from traditional Chinese medicine,” Scientific Reports, vol. 3, p. 844, 2013. View at Google Scholar
  52. K. C. Chen, S. S. Chang, H. J. Huang et al., “Three-in-one agonists for PPAR-alpha, PPAR-gamma, and PPAR-delta from traditional Chinese medicine,” Journal of Biomolecular Structure and Dynamics, vol. 30, no. 6, pp. 662–683, 2012. View at Google Scholar
  53. K. C. Chen, M. F. Sun, S. C. Yang et al., “Investigation into potent inflammation inhibitors from traditional Chinese medicine,” Chemical Biology and Drug Design, vol. 78, no. 4, pp. 679–688, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. S. S. Chang, H. J. Huang, and C. Y. Chen, “Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine,” PLoS Computational Biology, vol. 7, no. 12, Article ID e1002315, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. T. T. Chang, M. F. Sun, H. Y. Chen et al., “Screening from the world's largest TCM database against H1N1 virus,” Journal of Biomolecular Structure and Dynamics, vol. 28, no. 5, pp. 773–786, 2011. View at Google Scholar · View at Scopus
  56. S. C. Yang, S. S. Chang, H. Y. Chen, and C. Y. C. Chen, “Identification of potent EGFR inhibitors from TCM database@Taiwan,” PLoS Computational Biology, vol. 7, no. 10, Article ID e1002189, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. C. D. Fjell, J. A. Hiss, R. E. W. Hancock, and G. Schneider, “Designing antimicrobial peptides: form follows function,” Nature Reviews, vol. 11, no. 1, pp. 37–51, 2012. View at Google Scholar · View at Scopus
  58. B. K. Shoichet and B. K. Kobilka, “Structure-based drug screening for G-protein-coupled receptors,” Trends in Pharmacological Sciences, vol. 33, no. 5, pp. 268–272, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. C. Mooney, N. J. Haslam, T. A. Holton et al., “PeptideLocator: prediction of bioactive peptides in protein sequences,” Bioinformatics, vol. 29, no. 9, pp. 1120–1126, 2013. View at Google Scholar
  60. V. J. Hruby, “Designing peptide receptor agonists and antagonists,” Nature Reviews, vol. 1, no. 11, pp. 847–858, 2002. View at Publisher · View at Google Scholar · View at Scopus
  61. K. S. Lam, S. E. Salmon, E. M. Hersh, V. J. Hruby, W. M. Kazmierski, and R. J. Knapp, “A new type of synthetic peptide library for identifying ligand-binding activity,” Nature, vol. 353, no. 6348, pp. 82–84, 1991. View at Google Scholar · View at Scopus
  62. R. A. Houghten, C. Pinilla, S. E. Blondelle, J. R. Appel, T. Dooley, and J. H. Cuervo, “Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery,” Nature, vol. 353, no. 6348, pp. 84–86, 1991. View at Google Scholar · View at Scopus
  63. C. Y. C. Chen, “TCM database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in Silico,” PLoS ONE, vol. 6, no. 1, Article ID e15939, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. T. Duchrow, T. Shtatland, D. Guettler, M. Pivovarov, S. Kramer, and R. Weissleder, “Enhancing navigation in biomedical databases by community voting and database-driven text classification,” BMC Bioinformatics, vol. 10, article 1471, p. 317, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. L. Doedens, F. Opperer, M. Cai et al., “Multiple N -methylation of MT-II backbone amide bonds leads to melanocortin receptor subtype hMC1R selectivity: pharmacological and conformational studies,” Journal of the American Chemical Society, vol. 132, no. 23, pp. 8115–8128, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. D. Baker and A. Sali, “Protein structure prediction and structural genomics,” Science, vol. 294, no. 5540, pp. 93–96, 2001. View at Publisher · View at Google Scholar · View at Scopus
  67. B. R. Brooks, C. L. Brooks III, A. D. Mackerell Jr. et al., “CHARMM: the biomolecular simulation program,” Journal of Computational Chemistry, vol. 30, no. 10, pp. 1545–1614, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. N. Friedman, M. Linial, I. Nachman, and D. Pe'er, “Using Bayesian networks to analyze expression data,” Journal of Computational Biology, vol. 7, no. 3-4, pp. 601–620, 2000. View at Publisher · View at Google Scholar · View at Scopus
  69. J. Yu, V. A. Smith, P. P. Wang, A. J. Hartemink, and E. D. Jarvis, “Advances to Bayesian network inference for generating causal networks from observational biological data,” Bioinformatics, vol. 20, no. 18, pp. 3594–3603, 2004. View at Publisher · View at Google Scholar · View at Scopus
  70. C. Y. Chen and W. I. Tou, “How to design a drug for the disordered proteins?” Drug Discovery Today, vol. 18, no. 19-20, pp. 910–915, 2013. View at Google Scholar
  71. W. I. Tou and C. Y. Chen, “May disordered protein cause serious drug side effect?” Drug Discovery Today, 2013. View at Publisher · View at Google Scholar
  72. W. L. Liao and F. j. Tsai, “Personalized medicine: a paradigm shift in healthcare,” BioMedicine, vol. 3, no. 2, pp. 66–72, 2013. View at Google Scholar
  73. F. J. Tsai, “Biomedicine brings the future nearer,” BioMedicine, vol. 1, no. 1, p. 1, 2011. View at Google Scholar
  74. F. J. Tsai, “Rare diseases: a mysterious puzzle,” BioMedicine, vol. 3, no. 2, p. 65, 2013. View at Google Scholar
  75. I. C. Chou, W. D. Lin, C. H. Wang et al., “Möbius syndrome in a male with XX/XY mosaicism,” BioMedicine, vol. 3, no. 2, pp. 102–104, 2013. View at Google Scholar
  76. C. C. Lee, C. H. Tsai, L. Wan et al., “Increased incidence of Parkinsonism among Chinese with β-glucosidase mutation in central Taiwan,” BioMedicine, vol. 3, no. 2, pp. 92–94, 2013. View at Google Scholar
  77. D. Y. Lin, F. J. Tsai, C. H. Tsai, and C. Y. Huang, “Mechanisms governing the protective effect of 17β-estradiol and estrogen receptors against cardiomyocyte injury,” BioMedicine, vol. 1, no. 1, pp. 21–28, 2011. View at Google Scholar
  78. C. H. Wang, W. D. Lin, D. T. Bau et al., “Appearance of acanthosis nigricans may precede obesity: an involvement of the insulin/IGF receptor signaling pathway,” BioMedicine, vol. 3, no. 2, pp. 82–87, 2013. View at Google Scholar
  79. Y. M. Chang, B. K. Velmurugan, W. W. Kuo et al., “Inhibitory effect of alpinate Oxyphyllae fructus extracts on Ang II-induced cardiac pathological remodeling-related pathways in H9c2 cardiomyoblast cells,” BioMedicine, vol. 3, no. 4, pp. 148–152, 2013. View at Google Scholar
  80. I. C. Chou, W. D. Lin, C. H. Wang et al., “Association analysis between Tourette's syndrome and two dopamine genes (DAT1, DBH) in Taiwanese children,” BioMedicine, vol. 3, no. 2, pp. 88–91, 2013. View at Google Scholar
  81. W. Y. Lin, H. P. Liu, J. S. Chang et al., “Genetic variations within the PSORS1 region affect Kawasaki disease development and coronary artery aneurysm formation,” BioMedicine, vol. 3, no. 2, pp. 73–81, 2013. View at Google Scholar